Genomewide transcriptomic profiling identifies a gene signature for predicting recurrence in early-stage hepatocellular carcinoma

Clin Transl Med. 2021 Jun;11(6):e405. doi: 10.1002/ctm2.405.

¹ Center for Gastrointestinal Research, Center from Translational Genomics and Oncology, Baylor Scott and White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.
² Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA.
³ Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
⁴ Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido, Japan.
⁵ Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
⁶ Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

No abstract available

Keywords: biomarker; gene panel; hepatocellular carcinoma; recurrence.

Publication types